UK NSC moves to 2-yearly open call cycle
UK NSC moves to 2-yearly open call cycle
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
New UK NSC guidance explains how conflicts of interest can be mitigated
New UK NSC guidance explains how the committee decides if action is required to mitigate declared conflicts of interest by stakeholders and members.
English government endorses recommendation to screen newborns for tyrosinaemia
The English government has endorsed the UK National Screening Committee’s recommendation to add hereditary tyrosinaemia type 1 to the conditions screened for by the NHS Newborn Blood Spot Screening Programme.
SMA ISE clinical pathway expert sub-group meets for first time
SMA screening in-service evaluation clinical pathway group holds its first meeting.
Screening workstreams prominent in England Rare Diseases Action Plan
The UK National Screening Committee's (UK NSC's) work to improve the newborn screening evidence base features prominently in the England Rare Diseases Action Plan 2024.
Screening research: who does what?
Important factors, roles and responsibilities to consider for anyone wanting to conduct research or evaluation into screening.
Consultation opens on modifying antenatal screening pathway for Edwards' syndrome
The UK NSC is consulting on whether to add the quadruple test to the antenatal screening pathway for Edwards' syndrome.
Fascinating insight into potential benefits and limitations of using polygenic scores
The third UK NSC web-based seminar focused on the potential benefits and limitations of using polygenic scores to calculate the overall chance of developing a disease or condition.
Jo and Laura give positive feedback after completing health screening module
Bursary winners encourage other screening professionals to look into studying master's level health screening module.
UK NSC explores potential developments in bowel cancer screening
The UK National Screening Committee held a horizon scanning event in Edinburgh to explore potential developments in research, international policy making and emerging technologies related to bowel cancer screening.
Working in partnership to plan in-service evaluation of newborn screening for SMA
The UK NSC has held the inaugural meeting of the partnership board which will oversee the development of the in-service evaluation of newborn screening for spinal muscular atrophy in real world NHS services.